Denali Swings to $70.1M Third-Quarter Net Income
DNLI sits 41% above its 52-week low of $13.75.
Summary
Denali posted $70.1 million of third-quarter net income, or 37 cents of EPS, a sharp swing from the loss-making profile implied by its recent quarters, on $17.8 million of revenue. The profit was driven by a one-time gain. The result follows a Q2 10-Q that showed only $3.6 million of initial AVLAYAH revenue alongside the Phase 2b LUMA failure in Parkinson's, so profitability this quarter likely leans on non-recurring items rather than the core launch. For a company with a roughly $3.1 billion market cap, a $70 million quarterly profit is material and will force a re-read of the cash runway story. The headline carries no guidance detail, so the quality of the beat is unresolved until the full release and call.
At the time of this announcement, DNLI was trading at $19.45 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $13.75 to $27.30. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.